Epidemiological Characteristics, Antifungal Susceptibility, Risk Factors, and Outcomes of Candida Bloodstream Infection: A Ten-Year Surveillance in a Teaching Hospital in China
Yan Qiao,Zhaoyu Tao,Feiran Hao,Yongqiang Huang,Hong Sun,Pu Guo
DOI: https://doi.org/10.2147/IDR.S411283
2023-07-22
Infection and Drug Resistance
Abstract:Yan Qiao, 1, &ast Zhaoyu Tao, 2, &ast Feiran Hao, 3 Yongqiang Huang, 2 Hong Sun, 2 Pu Guo 2 1 Department of Infectious Disease, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, 233004, People's Republic of China; 2 Department of Clinical Laboratory Science, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, People's Republic of China; 3 Department of Clinical Medicine, School of Basic Medicine, Qiqihar Medical college, Hei Longjiang Qiqihar, 161006, People's Republic of China &astThese authors contributed equally to this work Correspondence: Pu Guo; Hong Sun, Department of Clinical Laboratory Science, The First Affiliated Hospital of Bengbu Medical College, 287 Zhihuai Road, Bengbu, 233004, People's Republic of China, Email ; Background: Candida is one of the most important pathogens of hospital-acquired bloodstream infections. Its morbidity and mortality are still high, which is a serious global public problem. Purpose: To investigate the strain distribution, drug susceptibility, clinical characteristics of patients, and risk factors affecting the prognosis of Candida bloodstream infection (BSI). Materials and Methods: We retrospectively collected the clinical data, infection-related indicators, prognosis, strain prevalence and drug susceptibility of 163 patients with Candida BSI in a teaching hospital from January 2012 to December 2022. Univariate and multivariate logistic regression were used to analyze the risk factors affecting the prognosis. Results: In 163 cases of Candida BSI, Candida albicans accounted for 48.47%, and Candida non -albicans accounted for 51.53%. A total of 163 patients with Candida BSI were mainly distributed in intensive care unit (ICU) and emergency department, accounting for 40.49% and 14.72%, respectively. The resistance rate of Candida albicans to fluconazole, itraconazole and voriconazole was less than 10%, and the sensitivity rate of Candida tropicalis to fluconazole, itraconazole and voriconazole was less than 80%. The mortality rate of 163 patients with Candida BSI was 33.13%, with Candida non- albicans higher than that of Candida albicans ( p = 0.04). Multivariate analysis showed that hemodialysis (OR = 0.199, 95% CI: 0.059– 0.673, P = 0.009), arteriovenous catheters (OR = 0.344, 95% CI: 0.130– 0.913, P = 0.032), elevated neutrophil count (OR = 0.409, 95% CI: 0.194– 0.862, P = 0.019) and APACHE II score ( OR = 0.848, 95% CI: 0.789~0.911, P < 0.001) were independent risk factors for death in patients with candidemia. Conclusion: The blood flow infection rate of Candida non- albicans is increasing, and the mortality rate and resistance to antifungal drugs are higher than that of Candida albicans . Hemodialysis, arteriovenous catheters, elevated neutrophil count and APACHE II score were associated with death in patients with Candida BSI. Keywords: Candida , bloodstream infection, clinical features, prognosis Candida exists widely in nature, is one of the conditioned pathogens of human body, and is also the most common pathogen causing fungal bloodstream infections. 1,2 Candida -caused bloodstream infections significantly prolong the length of hospital stay and cost, increase the mortality rate, and pose a serious threat to the health of patients. 3 Studies have found that there are differences in Candida species and epidemiological characteristics of bloodstream infections caused by different regions. Different from the results of studies in European countries, 4 the incidence of Candida non- albicans is on the rise in some parts of Asia, 5–7 and the resistance rate to antifungal drugs is also on the rise, resulting in poor efficacy and increased mortality. In addition, different species of Candida also have different prognoses in patients with bloodstream infection. Al-Dorzi et al, 8 in monitoring 174 patients with fungal bloodstream infections at a Saudi hospital ICU, found higher mortality for C. albicans compared with C. non- albicans . However, in a study in a Thai hospital, Candida tropicalis caused a higher mortality. 9 This regional difference suggests that we need to conduct necessary studies on Candida BSI in local hospitals. Recent studies have shown that risk factors for Candida BSI vary with time and region. Curren -Abstract Truncated-
pharmacology & pharmacy,infectious diseases